MassMutual Private Wealth & Trust’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
S
TCMG
OC
OAM
SO
MassMutual Private Wealth & Trust's NVAX Position: Q2 2026 in Review
MassMutual Private Wealth & Trust sold out of Novavax (NVAX) in Q2 2026, closing a stake of 75 shares — an estimated $611 sold.
MassMutual Private Wealth & Trust first reported a position in NVAX in Q2 2016 and held it in 16 quarters. The position peaked at $11K in Q4 2020. 70 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- MassMutual Private Wealth & Trust reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
- MassMutual Private Wealth & Trust sold 75 Novavax shares in Q2 2026, an estimated $611.
- MassMutual Private Wealth & Trust first reported a position in Novavax in Q2 2016 and held it in 16 quarters.
- MassMutual Private Wealth & Trust's Novavax position peaked at $11K in Q4 2020.
- 70 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.